1 Liposomal Verteporfin Market Overview 1.1 Liposomal Verteporfin Product Overview 1.2 Liposomal Verteporfin Market Segment by Type 1.2.1 Brands 1.2.2 Generic 1.3 Global Liposomal Verteporfin Market Size by Type 1.3.1 Global Liposomal Verteporfin Market Size Overview by Type (2016-2027) 1.3.2 Global Liposomal Verteporfin Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Liposomal Verteporfin Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Liposomal Verteporfin Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Liposomal Verteporfin Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Liposomal Verteporfin Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Liposomal Verteporfin Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Liposomal Verteporfin Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Liposomal Verteporfin Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Liposomal Verteporfin Sales Breakdown by Type (2016-2021) 1.4.2 Europe Liposomal Verteporfin Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Liposomal Verteporfin Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Liposomal Verteporfin Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Liposomal Verteporfin Sales Breakdown by Type (2016-2021) 2 Global Liposomal Verteporfin Market Competition by Company 2.1 Global Top Players by Liposomal Verteporfin Sales (2016-2021) 2.2 Global Top Players by Liposomal Verteporfin Revenue (2016-2021) 2.3 Global Top Players Liposomal Verteporfin Price (2016-2021) 2.4 Global Top Manufacturers Liposomal Verteporfin Manufacturing Base Distribution, Sales Area, Product Type 2.5 Liposomal Verteporfin Market Competitive Situation and Trends 2.5.1 Liposomal Verteporfin Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Liposomal Verteporfin Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomal Verteporfin as of 2020) 2.7 Date of Key Manufacturers Enter into Liposomal Verteporfin Market 2.8 Key Manufacturers Liposomal Verteporfin Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Liposomal Verteporfin Status and Outlook by Region 3.1 Global Liposomal Verteporfin Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Liposomal Verteporfin Historic Market Size by Region 3.2.1 Global Liposomal Verteporfin Sales in Volume by Region (2016-2021) 3.2.2 Global Liposomal Verteporfin Sales in Value by Region (2016-2021) 3.2.3 Global Liposomal Verteporfin Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Liposomal Verteporfin Forecasted Market Size by Region 3.3.1 Global Liposomal Verteporfin Sales in Volume by Region (2022-2027) 3.3.2 Global Liposomal Verteporfin Sales in Value by Region (2022-2027) 3.3.3 Global Liposomal Verteporfin Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Liposomal Verteporfin by Application 4.1 Liposomal Verteporfin Market Segment by Application 4.1.1 Hospital 4.1.2 Drugs Store 4.2 Global Liposomal Verteporfin Market Size by Application 4.2.1 Global Liposomal Verteporfin Market Size Overview by Application (2016-2027) 4.2.2 Global Liposomal Verteporfin Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Liposomal Verteporfin Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Liposomal Verteporfin Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Liposomal Verteporfin Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Liposomal Verteporfin Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Liposomal Verteporfin Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Liposomal Verteporfin Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Liposomal Verteporfin Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Liposomal Verteporfin Sales Breakdown by Application (2016-2021) 4.3.2 Europe Liposomal Verteporfin Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Liposomal Verteporfin Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Liposomal Verteporfin Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Liposomal Verteporfin Sales Breakdown by Application (2016-2021) 5 North America Liposomal Verteporfin by Country 5.1 North America Liposomal Verteporfin Historic Market Size by Country 5.1.1 North America Liposomal Verteporfin Sales in Volume by Country (2016-2021) 5.1.2 North America Liposomal Verteporfin Sales in Value by Country (2016-2021) 5.2 North America Liposomal Verteporfin Forecasted Market Size by Country 5.2.1 North America Liposomal Verteporfin Sales in Volume by Country (2022-2027) 5.2.2 North America Liposomal Verteporfin Sales in Value by Country (2022-2027) 6 Europe Liposomal Verteporfin by Country 6.1 Europe Liposomal Verteporfin Historic Market Size by Country 6.1.1 Europe Liposomal Verteporfin Sales in Volume by Country (2016-2021) 6.1.2 Europe Liposomal Verteporfin Sales in Value by Country (2016-2021) 6.2 Europe Liposomal Verteporfin Forecasted Market Size by Country 6.2.1 Europe Liposomal Verteporfin Sales in Volume by Country (2022-2027) 6.2.2 Europe Liposomal Verteporfin Sales in Value by Country (2022-2027) 7 Asia-Pacific Liposomal Verteporfin by Region 7.1 Asia-Pacific Liposomal Verteporfin Historic Market Size by Region 7.1.1 Asia-Pacific Liposomal Verteporfin Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Liposomal Verteporfin Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Liposomal Verteporfin Forecasted Market Size by Region 7.2.1 Asia-Pacific Liposomal Verteporfin Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Liposomal Verteporfin Sales in Value by Region (2022-2027) 8 Latin America Liposomal Verteporfin by Country 8.1 Latin America Liposomal Verteporfin Historic Market Size by Country 8.1.1 Latin America Liposomal Verteporfin Sales in Volume by Country (2016-2021) 8.1.2 Latin America Liposomal Verteporfin Sales in Value by Country (2016-2021) 8.2 Latin America Liposomal Verteporfin Forecasted Market Size by Country 8.2.1 Latin America Liposomal Verteporfin Sales in Volume by Country (2022-2027) 8.2.2 Latin America Liposomal Verteporfin Sales in Value by Country (2022-2027) 9 Middle East and Africa Liposomal Verteporfin by Country 9.1 Middle East and Africa Liposomal Verteporfin Historic Market Size by Country 9.1.1 Middle East and Africa Liposomal Verteporfin Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Liposomal Verteporfin Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Liposomal Verteporfin Forecasted Market Size by Country 9.2.1 Middle East and Africa Liposomal Verteporfin Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Liposomal Verteporfin Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Liposomal Verteporfin Business 10.1 Novartis 10.1.1 Novartis Corporation Information 10.1.2 Novartis Introduction and Business Overview 10.1.3 Novartis Liposomal Verteporfin Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Novartis Liposomal Verteporfin Products Offered 10.1.5 Novartis Recent Development 10.2 Bausch & Lomb 10.2.1 Bausch & Lomb Corporation Information 10.2.2 Bausch & Lomb Introduction and Business Overview 10.2.3 Bausch & Lomb Liposomal Verteporfin Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Novartis Liposomal Verteporfin Products Offered 10.2.5 Bausch & Lomb Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Liposomal Verteporfin Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Liposomal Verteporfin Industrial Chain Analysis 11.4 Liposomal Verteporfin Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Liposomal Verteporfin Distributors 12.3 Liposomal Verteporfin Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Brands Table 2. Major Company of Generic Table 3. Global Liposomal Verteporfin Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Liposomal Verteporfin Sales by Type (2016-2021) & (K Units) Table 5. Global Liposomal Verteporfin Sales Market Share in Volume by Type (2016-2021) Table 6. Global Liposomal Verteporfin Sales by Type (2016-2021) & (US& Million) Table 7. Global Liposomal Verteporfin Market Share in Value by Type (2016-2021) Table 8. Global Liposomal Verteporfin Price by Type (2016-2021) & (US$/Unit) Table 9. Global Liposomal Verteporfin Sales by Type (2022-2027) & (K Units) Table 10. Global Liposomal Verteporfin Sales Market Share in Volume by Type (2022-2027) Table 11. Global Liposomal Verteporfin Sales by Type (2022-2027) & (US$ Million) Table 12. Global Liposomal Verteporfin Sales Market Share in Value by Type (2022-2027) Table 13. Global Liposomal Verteporfin Price by Type (2022-2027) & (US$/Unit) Table 14. North America Liposomal Verteporfin Sales by Type (2016-2021) & (K Units) Table 15. North America Liposomal Verteporfin Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Liposomal Verteporfin Sales (K Units) by Type (2016-2021) Table 17. Europe Liposomal Verteporfin Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Liposomal Verteporfin Sales (K Units) by Type (2016-2021) Table 19. Asia-Pacific Liposomal Verteporfin Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Liposomal Verteporfin Sales (K Units) by Type (2016-2021) Table 21. Latin America Liposomal Verteporfin Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Liposomal Verteporfin Sales (K Units) by Type (2016-2021) Table 23. Middle East and Africa Liposomal Verteporfin Sales by Type (2016-2021) & (US$ Million) Table 24. Global Liposomal Verteporfin Sales by Company (2016-2021) & (K Units) Table 25. Global Liposomal Verteporfin Sales Share by Company (2016-2021) Table 26. Global Liposomal Verteporfin Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Liposomal Verteporfin Revenue Share by Company (2016-2021) Table 28. Global Market Liposomal Verteporfin Price by Company (2016-2021) & (US$/Unit) Table 29. Global Liposomal Verteporfin Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Liposomal Verteporfin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomal Verteporfin as of 2020 Table 32. Date of Key Manufacturers Enter into Liposomal Verteporfin Market Table 33. Key Manufacturers Liposomal Verteporfin Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Liposomal Verteporfin Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Liposomal Verteporfin Sales by Region (2016-2021) & (K Units) Table 37. Global Liposomal Verteporfin Sales Market Share in Volume by Region (2016-2021) Table 38. Global Liposomal Verteporfin Sales by Region (2016-2021) & (US$ Million) Table 39. Global Liposomal Verteporfin Sales Market Share in Value by Region (2016-2021) Table 40. Global Liposomal Verteporfin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 41. Global Liposomal Verteporfin Sales by Region (2022-2027) & (K Units) Table 42. Global Liposomal Verteporfin Sales Market Share in Volume by Region (2022-2027) Table 43. Global Liposomal Verteporfin Sales by Region (2022-2027) & (US$ Million) Table 44. Global Liposomal Verteporfin Sales Market Share in Value by Region (2022-2027) Table 45. Global Liposomal Verteporfin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027) Table 46. Global Liposomal Verteporfin Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Liposomal Verteporfin Sales by Application (2016-2021) & (K Units) Table 48. Global Liposomal Verteporfin Sales Market Share in Volume by Application (2016-2021) Table 49. Global Liposomal Verteporfin Sales by Application (2016-2021) & (US$ Million) Table 50. Global Liposomal Verteporfin Sales Market Share in Value by Application (2016-2021) Table 51. Global Liposomal Verteporfin Price by Application (2016-2021) & (US$/Unit) Table 52. Global Liposomal Verteporfin Sales by Application (2022-2027) & (K Units) Table 53. Global Liposomal Verteporfin Sales Market Share in Volume by Application (2022-2027) Table 54. Global Liposomal Verteporfin Sales by Application (2022-2027) & (US$ Million) Table 55. Global Liposomal Verteporfin Sales Market Share in Value by Application (2022-2027) Table 56. Global Liposomal Verteporfin Price by Application (2022-2027) & (US$/Unit) Table 57. North America Liposomal Verteporfin Sales by Application (2016-2021) (K Units) Table 58. North America Liposomal Verteporfin Sales by Application (2016-2021) & (US$ Million) Table 59. North America Liposomal Verteporfin Sales Market Share in Value by Application in 2020 Table 60. Europe Liposomal Verteporfin Sales by Application (2016-2021) (K Units) Table 61. Europe Liposomal Verteporfin Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Liposomal Verteporfin Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Liposomal Verteporfin Sales by Application (2016-2021) (K Units) Table 64. Asia-Pacific Liposomal Verteporfin Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Liposomal Verteporfin Sales Market Share in Value by Application in 2020 Table 66. Latin America Liposomal Verteporfin Sales by Application (2016-2021) (K Units) Table 67. Latin America Liposomal Verteporfin Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Liposomal Verteporfin Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Liposomal Verteporfin Sales by Application (2016-2021) (K Units) Table 70. Middle East and Africa Liposomal Verteporfin Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Liposomal Verteporfin Sales Market Share in Value by Application in 2020 Table 72. North America Liposomal Verteporfin Sales by Country (2016-2021) & (K Units) Table 73. North America Liposomal Verteporfin Sales Market Share in Volume by Country (2016-2021) Table 74. North America Liposomal Verteporfin Sales by Country (2016-2021) & (US$ Million) Table 75. North America Liposomal Verteporfin Sales Market Share in Value by Country (2016-2021) Table 76. North America Liposomal Verteporfin Sales by Country (2022-2027) & (K Units) Table 77. North America Liposomal Verteporfin Sales Market Share in Volume by Country (2022-2027) Table 78. North America Liposomal Verteporfin Sales by Country (2022-2027) & (US$ Million) Table 79. North America Liposomal Verteporfin Sales Market Share in Value by Country (2022-2027) Table 80. Europe Liposomal Verteporfin Sales by Country (2016-2021) & (K Units) Table 81. Europe Liposomal Verteporfin Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Liposomal Verteporfin Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Liposomal Verteporfin Sales Market Share in Value by Country (2016-2021) Table 84. Europe Liposomal Verteporfin Sales by Country (2022-2027) & (K Units) Table 85. Europe Liposomal Verteporfin Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Liposomal Verteporfin Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Liposomal Verteporfin Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Liposomal Verteporfin Sales by Region (2016-2021) & (K Units) Table 89. Asia-Pacific Liposomal Verteporfin Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Liposomal Verteporfin Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Liposomal Verteporfin Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Liposomal Verteporfin Sales by Region (2022-2027) & (K Units) Table 93. Asia-Pacific Liposomal Verteporfin Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Liposomal Verteporfin Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Liposomal Verteporfin Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Liposomal Verteporfin Sales by Country (2016-2021) & (K Units) Table 97. Latin America Liposomal Verteporfin Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Liposomal Verteporfin Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Liposomal Verteporfin Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Liposomal Verteporfin Sales by Country (2022-2027) & (K Units) Table 101. Latin America Liposomal Verteporfin Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Liposomal Verteporfin Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Liposomal Verteporfin Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Liposomal Verteporfin Sales by Country (2016-2021) & (K Units) Table 105. Middle East and Africa Liposomal Verteporfin Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Liposomal Verteporfin Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Liposomal Verteporfin Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Liposomal Verteporfin Sales by Country (2022-2027) & (K Units) Table 109. Middle East and Africa Liposomal Verteporfin Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Liposomal Verteporfin Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Liposomal Verteporfin Sales Market Share in Value by Country (2022-2027) Table 112. Novartis Corporation Information Table 113. Novartis Introduction and Business Overview Table 114. Novartis Liposomal Verteporfin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 115. Novartis Liposomal Verteporfin Product Table 116. Novartis Recent Development Table 117. Bausch & Lomb Corporation Information Table 118. Bausch & Lomb Introduction and Business Overview Table 119. Bausch & Lomb Liposomal Verteporfin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 120. Bausch & Lomb Liposomal Verteporfin Product Table 121. Bausch & Lomb Recent Development Table 122. Key Raw Materials Lists Table 123. Raw Materials Key Suppliers Lists Table 124. Liposomal Verteporfin Market Trends Table 125. Liposomal Verteporfin Market Drivers Table 126. Liposomal Verteporfin Market Challenges Table 127. Liposomal Verteporfin Market Restraints Table 128. Liposomal Verteporfin Distributors List Table 129. Liposomal Verteporfin Downstream Customers Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Liposomal Verteporfin Product Picture Figure 2. Global Liposomal Verteporfin Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Liposomal Verteporfin Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Liposomal Verteporfin Sales Status and Outlook (2016-2027) & (K Units) Figure 5. Product Picture of Brands Figure 6. Global Brands Sales YoY Growth (2016-2021) & (K Units) Figure 7. Product Picture of Generic Figure 8. Global Generic Sales YoY Growth (2016-2021) & (K Units) Figure 9. Global Liposomal Verteporfin Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Liposomal Verteporfin Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Liposomal Verteporfin Sales Market Share in Value by Type (2016-2021) Figure 12. Global Liposomal Verteporfin Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Liposomal Verteporfin Sales Market Share in Value by Type (2022-2027) Figure 14. North America Liposomal Verteporfin Sales Market Share in Volume by Type in 2020 Figure 15. North America Liposomal Verteporfin Sales Market Share in Value by Type in 2020 Figure 16. Europe Liposomal Verteporfin Sales Market Share in Volume by Type in 2020 Figure 17. Europe Liposomal Verteporfin Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Liposomal Verteporfin Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Liposomal Verteporfin Sales Market Share in Value by Type in 2020 Figure 20. Latin America Liposomal Verteporfin Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Liposomal Verteporfin Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Liposomal Verteporfin Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Liposomal Verteporfin Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Liposomal Verteporfin Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Liposomal Verteporfin Revenue in 2020 Figure 26. Liposomal Verteporfin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Hospital Figure 28. Global Hospital Sales YoY Growth (2016-2027) & (K Units) Figure 29. Product Picture of Drugs Store Figure 30. Global Drugs Store Sales YoY Growth (2016-2027) & (K Units) Figure 31. Global Liposomal Verteporfin Sales by Application (2016-2027) & (US$ Million) Figure 32. Global Liposomal Verteporfin Sales Market Share in Volume by Application (2016-2021) Figure 33. Global Liposomal Verteporfin Sales Market Share in Value by Application (2016-2021) Figure 34. Global Liposomal Verteporfin Sales Market Share in Volume by Application (2022-2027) Figure 35. North America Liposomal Verteporfin Sales Market Share in Volume by Application in 2020 Figure 36. Latin America Liposomal Verteporfin Sales Market Share in Value by Application in 2020 Figure 37. Middle East and Africa Liposomal Verteporfin Sales Market Share in Value by Application in 2020 Figure 38. Key Raw Materials Price Figure 39. Liposomal Verteporfin Manufacturing Cost Structure Figure 40. Liposomal Verteporfin Industrial Chain Analysis Figure 41. Channels of Distribution Figure 42. Distributors Profiles Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation Figure 45. Key Executives Interviewed

Novartis Bausch & Lomb